Healthcare
Phaos Technology Holdings (Caym(POAS)
Live Price
Offline$0.322
-5.85% today
Window Change
-34.95%
Window
May 29, 2026 → Jun 18, 2026
- Market Cap
- $40.00M
- Revenue Growth
- -91.1%
- EPS Growth
- -116.7%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Phaos Technology Holdings (Caym (POAS) is a Healthcare stock with a market cap of $40.00M and listed on AMEX. The stock last traded around $0.32 and down 34.9% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of -91.1%, EPS growth of -116.7%, a dividend yield of 0.0%. What stands out right now is revenue -91.1%, EPS -116.7%, free cash flow -125.0% with operating margin -3148.3% and ROIC 311.1%. Valuation already assumes a fairly strong business story at price/sales 241.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines POAS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-91.1% vs +7.6% peer median
Operating Margin
Below sector median
-3148.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -91.1% and EPS is at -116.7%, with operating margin around -3148.3%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
POAS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
POAS Max Drawdown
-45.86%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for POAS and SPY.
Company Overview
Phaos Technology Holdings (Caym
New York Stock Exchange American
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
- Leadership
- Hong Loon Gan
- IPO Date
- Nov 13, 2025
- Employees
- 25
- Street Address
- 83 Science Park Dr
- Mailing
- Singapore, 118258
- Region
- Singapore, SG
- Reporting Currency
- USD
- Investor Line
- 65 6250 3877
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 241.4
- Price/Book
- —
Growth
- Revenue
- -91.1%
- EPS
- -116.7%
- Free Cash Flow
- -125.0%
Profitability
- Gross Margin
- 22.1%
- Operating Margin
- -3148.3%
- Net Margin
- -3063.1%
- ROE
- -1073.1%
- ROIC
- 311.1%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.40
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.